Clean area

Who is novosanis

Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests for infectious diseases and oncology.

Read more
Colli Pee Novosanis

Our products

Improving the quality of diagnostics by volumetric self-sampling of first-void (first catch) urine

Learn more
Colli-Pee in a box

Home collection

Improving the quality of home-based urine collection by easy self-sampling, alongside postal packaging

Learn more

Latest news

View all news

Novosanis turns 8!

12/03/2021
What a milestone! 8 years and counting. To celebrate our 8th anniversary, we asked our team members to describe Novosanis and their experience in unique words. Teamwork and Innovation were in the top 2. Thank you to everyone who has been part of this journey!
Read more

Latest blogpost

View all blogs

Blog Cervical & Ovarian cancer

Urine as a way to screen more women for gynecological cancers during a pandemic and beyond

6/04/2021
Urine as a liquid biopsy is attractive in the field of gynecological cancer research. Urine in conjunction with other diagnostic tools could help screen for these diseases more quickly and accurately, allowing treatment to start earlier, especially during a time where healthcare systems are stressed, but even beyond.
Read more

Upcoming event

View all events

Eurogin 2021

Eurogin 2021

Düsseldorf, Germany
Novosanis is excited to have a booth at EUROGIN, an international conference focusing on Human Papillomavirus (HPV). We look forward to speaking with you and discussing the potential of urine sampling in HPV detection through our innovative medical device, Colli-Pee.
Read more